Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1986 Mar;23(3):616–618. doi: 10.1128/jcm.23.3.616-618.1986

Two fatal cases of type E adult food-borne botulism with early symptoms and terminal neurologic signs.

H Badhey, D J Cleri, R F D'Amato, J R Vernaleo, V Veinni, J Tessler, A A Wallman, A J Mastellone, M Giuliani, L Hochstein
PMCID: PMC268705  PMID: 3514662

Abstract

Type E botulism, one of the least common forms of botulinal intoxication on the East Coast of the United States, is described for two elderly patients with chronic underlying disease. Both patients consumed tainted kapchunka, a salted, ungutted whitefish. Gastrointestinal symptoms and signs were prominent, but neurologic complaints, although noted soon after the consumption of the fish in one patient, did not progress until late in the course of the patient's illness. One patient exhibited both urinary retention, which was reported mainly in one outbreak of type E botulism (M.G. Koenig, A. Spickard, M.A. Cardella, and D.E. Rogers, Medicine [Baltimore] 43:517-545, 1964), and muscular fasciculations, which have been rarely reported.

Full text

PDF
616

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong R. W., Stenn F., Dowell V. R., Jr, Ammerman G., Sommers H. M. Type E botulism from home-canned gefilte fish. Report of three cases. JAMA. 1969 Oct 13;210(2):303–305. [PubMed] [Google Scholar]
  2. Black R. E., Gunn R. A. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med. 1980 Oct;69(4):567–570. doi: 10.1016/0002-9343(80)90469-6. [DOI] [PubMed] [Google Scholar]
  3. Blettery B., Soichot P., Virot C., Lorcerie B., Hillon P. Le botulisme de type E. Deux observations récentes. Nouv Presse Med. 1982 Apr 3;11(15):1131–1133. [PubMed] [Google Scholar]
  4. Horwitz M. A., Hughes J. M., Merson M. H., Gangarosa E. J. Food-borne botulism in the United States, 1970-1975. J Infect Dis. 1977 Jul;136(1):153–159. doi: 10.1093/infdis/136.1.153. [DOI] [PubMed] [Google Scholar]
  5. KOENIG M. G., SPICKARD A., CARDELLA M. A., ROGERS D. E. CLINICAL AND LABORATORY OBSERVATIONS ON TYPE E BOTULISM IN MAN. Medicine (Baltimore) 1964 Sep;43:517–545. doi: 10.1097/00005792-196409000-00001. [DOI] [PubMed] [Google Scholar]
  6. Kinzel T. Botulism in the elderly. J Am Geriatr Soc. 1984 Nov;32(11):868–871. doi: 10.1111/j.1532-5415.1984.tb06307.x. [DOI] [PubMed] [Google Scholar]
  7. MASLAND R. L., GAMMON G. D. The effect of botulinus toxin on the electromyogram. J Pharmacol Exp Ther. 1949 Dec;97(4):499–506. [PubMed] [Google Scholar]
  8. Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev. 1980 Sep;44(3):419–448. doi: 10.1128/mr.44.3.419-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Tacket C. O., Shandera W. X., Mann J. M., Hargrett N. T., Blake P. A. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med. 1984 May;76(5):794–798. doi: 10.1016/0002-9343(84)90988-4. [DOI] [PubMed] [Google Scholar]
  10. WHITTAKER R. L., GILBERTSON R. B., GARRETT A. S., Jr BOTULISM, TYPE E; REPORT OF EIGHT SIMULTANEOUS CASES. Ann Intern Med. 1964 Sep;61:448–454. doi: 10.7326/0003-4819-61-3-448. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES